Find Reports

Select Report Type

Learn More about Reports

Reimbursement Review

Displaying 1401 - 1422 of 1422

Health Technology Review

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 576 - 600 of 600

Horizon Scan

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 101 - 110 of 110

Projects in Progress

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 26 - 27 of 27

View All Reports

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 1626 - 1650 of 2132

Please scroll or swipe to the right to view the full content.

Title	Files	Last Updated Sort ascending	Project Line	Status	Project Number
Fluorouracil and Salicylic Acid	cdr_SR0498_Actikerall.pdf SR0498_complete_Actikerall-Mar-24-17.pdf SR0498_Actikerall_CL_Report.pdf SR0498_Actikerall_PE_Report.pdf	Aug 4, 2016	Reimbursement Review	Complete	SR0498-000
Imbruvica for Mantle Cell Lymphoma (relapsed/refractory)	pcodr-provfund_ibrutinib_imbruvica_mcl.pdf pcodr_ibrutinib_imbruvica_mcl_fn_rec.pdf pcodr_ibrutinib_imbruvica_mcl_fn_cgr.pdf pcodr_ibrutinib_imbruvica_mcl_fn_egr.pdf pcodr_ibrutinib_imbruvica_mcl_in_rec.pdf pcodr_ibrutinib_imbruvica_mcl_pagfdk.pdf pcodr_ibrutinib_imbruvica_mcl_fdk_janssen.pdf pcodr_ibrutinib_imbruvica_mcl_ptfdk_lfc.pdf pcodr_ibrutinib_imbruvica_mcl_ptfdk_llsc-ccsn.pdf pcodr_ibrutinib_imbruvica_mcl_coi_lfc.pdf pcodr_ibrutinib_imbruvica_mcl_coi_llsc-ccsn.pdf	Aug 4, 2016	Reimbursement Review	Complete	PC0073-000
glycerol phenylbutyrate	cdr_SR0497_Ravicti.pdf SR0497_complete_Ravicti_Mar-23-17.pdf SR0497_Ravicti_CL_Report.pdf SR0497_Ravicti_PE_Report.pdf SR0497_Ravicti_PI_Submissions.pdf	Aug 2, 2016	Reimbursement Review	Complete	SR0497-000
Propranolol oral solution	cdr_SR0496_Hemangiol.pdf SR0496_complete_Hemangiol-Feb-23_17.pdf SR0496_Hemangiol_CL_Report.pdf SR0496_Hemangiol_PE_Report.pdf SR0496_Hemangiol_PI_Submissions.pdf	Jul 27, 2016	Reimbursement Review	Complete	SR0496-000
Ibrance for Advanced Breast Cancer – Details	pcodr_palbociclib_ibrance_abc_rec.pdf pcodr_palbociclib_ibrance_abc_cgr.pdf pcodr_palbociclib_ibrance_abc_egr.pdf	Jul 25, 2016	Reimbursement Review	Withdrawn	PC0068-000
Cotellic for Metastatic Melanoma – Details	pcodr_provfund_cobimetinib_cotellic_metmela.pdf pcodr_cobimetinib_cotellic_metmela_fn_rec.pdf pcodr_cobimetinib_cotellic_metmela_fn_cgr.pdf pcodr_cobimetinib_cotellic_metmela_fn_egr.pdf pcodr_cobimetinib_cotellic_metmela_in_rec.pdf pcodr_cobimetinib_cotellic_metmela_pagfdk.pdf pcodr_cobimetinib_cotellic_metmela_fdk_roche.pdf pcodr_cobimetinib_cotellic_metmela_ptgrpfdk.pdf pcodr_cobimetinib_cotellic_metmela_coi_mnc.pdf pcodr_cobimetinib_cotellic_metmela_coi_sysf.pdf	Jul 18, 2016	Reimbursement Review	Complete	PC0070-000
Adcetris for Hodgkin Lymphoma (post-ASCT consolidation) – Details		Jul 7, 2016	Reimbursement Review	Withdrawn	PC0086-000
Fentanyl buccal	cdr_SR0494_Fentora.pdf SR0494_Fentora_CL_Report.pdf SR0494_Fentora_PE_Report.pdf SR0494_complete_Fentora_Feb-23-17.pdf	Jun 10, 2016	Reimbursement Review	Complete	SR0494-000
Edoxaban	cdr_SR0500_Lixiana_NVAF.pdf SR0500_complete_Lixiana-NVAF_Mar-23-17.pdf SR0500_Lixiana_NVAF_CL_Report.pdf SR0500_Lixiana_NVAF_PE_Report.pdf	Jun 8, 2016	Reimbursement Review	Complete	SR0500-000
Edoxaban	cdr_SR0499_Lixiana_VTE.pdf SR0499_complete_Lixiana_VTE_May_29_17_e.pdf SR0499_Lixiana_VTE_CL_Report.pdf SR0499_Lixiana_VTE_PE_Report.pdf	Jun 8, 2016	Reimbursement Review	Complete	SR0499-000
Cyramza for Non-Small Cell Lung Cancer - Details		May 20, 2016	Reimbursement Review	Cancelled	PC0078-000
Idarucizumab (Drug Plan Submission)	cdr_SR0492_Praxbind.pdf	May 17, 2016	Reimbursement Review	Withdrawn	SR0492-000
Reslizumab	cdr_SR0495_Cinqair.pdf SR0495_complete_Cinqair-Mar-24-17.pdf SR0495_Cinqair_CL_Report.pdf SR0495_Cinqair_PE_Report.pdf SR0495_Cinqair_PI_Submissions.pdf	May 4, 2016	Reimbursement Review	Complete	SR0495-000
Levofloxacin	cdr_SR0493_Quinsair.pdf SR0493_complete_Quinsair_Nov-23-16.pdf SR0493_Quinsair_CL_Report.pdf SR0493_Quinsair_PE_Report.pdf SR0493_Quinsair_PI_Submissions.pdf	May 2, 2016	Reimbursement Review	Complete	SR0493-000
Budesonide	cdr_SR0491_TBC.pdf SR0491_complete_Cortiment-Mar-24-17.pdf SR0491_Cortiment_CL_Report.pdf SR0491_Cortiment_PE_Report.pdf SR0491 Cortiment_PI_Submissions.pdf	Apr 26, 2016	Reimbursement Review	Complete	SR0491-000
Blinatumomab (Blincyto) for Ph- ALL	pcodr_profund_blinatumomab_blincyto_all.pdf blinatumomab_blincyto_all_fn_rec.pdf blinatumomab_blincyto_all_fn_cgr.pdf blinatumomab_blincyto_all_fn_egr.pdf pcodr_blinatumomab_blincyto_all_in_rec.pdf blinatumomab_blincyto_all_pagfdk.pdf blinatumomab_blincyto_all_fdk_amgen.pdf blinatumomab_blincyto_all_ptfdk_ccsn.pdf blinatumomab_blincyto_all_coi_ccsn.pdf	Apr 18, 2016	Reimbursement Review	Complete	PC0064-000
Opdivo for Metastatic Melanoma - Details	pcodr_provfund_nivolumab_opdivo_metmela.pdf nivolumab_opdivo_mm_fn_rec.pdf nivolumab_opdivo_mm_fn_cgr.pdf nivolumab_opdivo_mm_fn_egr.pdf pcodr_nivolumab_opdivo_metmela_in_rec.pdf nivolumab_opdivo_mm_pagfdk.pdf nivolumab_opdivo_mm_fdk_bms.pdf nivolumab_opdivo_mm_ptfdk_mnc.pdf nivolumab_opdivo_mm_coi_mnc.pdf	Apr 18, 2016	Reimbursement Review	Complete	PC0063-000
perindopril arginine / amlodipine	cdr_SR0490_Viacoram.pdf SR0490_complete_Viacoram-Oct-28-16.pdf SR0490_Viacoram_CL_Report.pdf SR0490_Viacoram_PE_Report.pdf	Apr 4, 2016	Reimbursement Review	Complete	SR0490-000
Guidance Document for the Costing of Health Care Resources in the Canadian Setting: Second Edition		Mar 30, 2016	Health Technology Review		MH0002-CP0009
Empagliflozin	cdr_SR0488_Jardiance.pdf SR0488_complete_Jardiance-Oct-28-16.pdf SR0488_Jardiance_CL_Report.pdf SR0488_Jardiance_PE_Report.pdf SR0488_Jardiance_PI_Submissions.pdf	Mar 30, 2016	Reimbursement Review	Complete	SR0488-000
Sofosbuvir/ velpatasvir	cdr_SR0486_TBC.pdf SR0486_complete_Epclusa-Oct-28-16.pdf SR0486_Epclusa_CL_Report.pdf SR0486_Epclusa_PE_Report.pdf SR0486_Epclusa_PI_Submissions.pdf	Mar 23, 2016	Reimbursement Review	Complete	SR0486-000
Vedolizumab	cdr_SR0487_Entyvio.pdf SR0487_complete_Entyvio-Oct-31-16.pdf SR0487_Entyvio_CL_Report.pdf SR0487_Entyvio_PE_Report.pdf SR0487_Entyvio_PI_Submissions.pdf	Mar 23, 2016	Reimbursement Review	Complete	SR0487-000
Jakavi for Polycythemia Vera - Details	pcodr_profund_ruxolitinib_jakavi_pv.pdf pcodr_ruxolitinib_jakavi_pv_fn_rec.pdf pcodr_ruxolitinib_jakavi_pv_fn_cgr.pdf pcodr_ruxolitinib_jakavi_pv_fn_egr.pdf pcodr_ruxolitinib_jakavi_pv_in_rec.pdf pcodr_ruxolitinib_jakavi_pv_pagfdk.pdf pcodr_ruxolitinib_jakavi_pv_fdk_novartis.pdf pcodr_ruxolitinib_jakavi_pv_ptfdk_mpn.pdf pcodr_ruxolitinib_jakavi_pv_coi_mpn.pdf	Mar 18, 2016	Reimbursement Review	Complete	PC0065-000
Brivaracetam	cdr_SR0484_Brivlera.pdf SR0484_Brivlera_CL_Report.pdf SR0484_Brivlera_PE_Report.pdf sr0484_complete_brivlera_jan-27-17.pdf	Mar 17, 2016	Reimbursement Review	Complete	SR0484-000
Infliximab	cdr_SE0483_Inflectra.pdf SE0483_IBD_Inflectra-Oct-28-16.pdf SE0483_Inflectra_PI_Submission_Consolidated.pdf SE0483_Inflectra_SEB_Report.pdf	Mar 11, 2016	Reimbursement Review	Complete	SE0483-000